Evidence map›Paper›PMID 29682036›Full record

ArticleAsian journal of neurosurgery

Effectiveness of Goreisan in Preventing Recurrence of Chronic Subdural Hematoma.

Shunsaku Goto, Kyozo Kato, Taiki Yamamoto, Shinji Shimato, Tomotaka Ohshima, Toshihisa Nishizawa

Open access · hybridAbstract read
In one paragraph

Article in Asian journal of neurosurgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Shunsaku GotoDepartment of Neurosurgery, Kariya Toyota General Hospital, Kariya, Japan.
Kyozo KatoDepartment of Neurosurgery, Kariya Toyota General Hospital, Kariya, Japan.
Taiki YamamotoDepartment of Neurosurgery, Kariya Toyota General Hospital, Kariya, Japan.
Shinji ShimatoDepartment of Neurosurgery, Kariya Toyota General Hospital, Kariya, Japan.
Tomotaka OhshimaDepartment of Neurosurgery, Kariya Toyota General Hospital, Kariya, Japan.
Toshihisa NishizawaDepartment of Neurosurgery, Kariya Toyota General Hospital, Kariya, Japan.
Kariya Toyota General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBurr-hole irrigation surgery is now recognized as a widespread simple technique for the treatment of chronic subdural hematoma (CSDH). However, recurrence of CSDH is sometimes experienced after initial surgery. Recently, it has been reported that goreisan is effective in preventing CSDH recurrence. MATERIALS AND

methodsMethods: We studied patients with CSDH who received burr-hole irrigation at our hospital between January 2011 and December 2014. We divided these patients into three groups. The first group was given goreisan during the early phase after burr-hole irrigation. The second group was given goreisan when there was a visual tendency of recurrence, as observed in the course of computed tomography imaging for outpatients. The third group was not given any drug.

resultsThe recurrence rate was compared between each group. The recurrence rate was significantly lower in the early goreisan administration group (5% vs. 12%,

conclusionsGoreisan is effective in preventing recurrence of CSDH after burr-hole irrigation.

Indexed as

Chronic subdural hematomagoreisanKamporecurrence

Identifiers

PMID29682036
PMCPMC5898107
OpenAlexW2795139559

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.